{"id":20988,"date":"2023-11-02T10:45:21","date_gmt":"2023-11-02T09:45:21","guid":{"rendered":"https:\/\/ggba.swiss\/abionic-and-lascco-partner-with-fapon-for-sepsis-diagnosis-in-china\/"},"modified":"2023-11-02T10:47:28","modified_gmt":"2023-11-02T09:47:28","slug":"abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/","title":{"rendered":"Abionic et Lascco s’associent \u00e0 Fapon pour le diagnostic du sepsis en Chine"},"content":{"rendered":"\n

Abionic<\/a>, en collaboration avec son partenaire technologique biom\u00e9dical Lascco<\/a>, a conclu un accord de licence exclusif avec Fapon<\/a>, une entreprise mondiale du secteur des sciences de la vie bas\u00e9e en Chine. Cette collaboration accordera \u00e0 Fapon une licence exclusive pour l’utilisation du biomarqueur PSP (pancreatic stone protein) pour le diagnostic de la septic\u00e9mie en Chine.<\/p>\n\n\n\n

Abionic, dont le si\u00e8ge se trouve sur le campus des sciences de la vie du Biop\u00f4le<\/a> \u00e0 Lausanne (canton de Vaud), est \u00e0 l’origine d’une technologie nanofluidique r\u00e9volutionnaire qui permet aux professionnels de la sant\u00e9 de disposer d’outils de diagnostic rapides et polyvalents. En particulier, leur plateforme de diagnostic in vitro (DIV) fournit des r\u00e9sultats de qualit\u00e9 laboratoire en seulement 5 minutes \u00e0 partir d’une seule goutte de sang, ce qui permet d’initier un traitement imm\u00e9diat.<\/p>\n\n\n\n

Le sepsis, une maladie potentiellement mortelle r\u00e9sultant d’une r\u00e9ponse d\u00e9r\u00e9gl\u00e9e aux infections, pose des d\u00e9fis importants en mati\u00e8re de diagnostic. Les m\u00e9thodes de d\u00e9tection traditionnelles sont souvent insuffisantes, n’ayant pas la pr\u00e9cision requise pour une d\u00e9tection pr\u00e9coce. En s’appuyant sur le dispositif abioSCOPE d’Abionic, Lascco a cr\u00e9\u00e9 un test qui d\u00e9tecte les niveaux du biomarqueur PSP, une prot\u00e9ine corr\u00e9l\u00e9e \u00e0 l’apparition et \u00e0 la gravit\u00e9 de la septic\u00e9mie. Ce test PSP signale l’apparition d’une septic\u00e9mie jusqu’\u00e0 trois jours avant le diagnostic clinique, offrant ainsi un outil de d\u00e9tection et d’intervention pr\u00e9coces qui change la donne.<\/p>\n\n\n\n

Une confiance mondiale croissante<\/h4>\n\n\n\n

L’ann\u00e9e derni\u00e8re, ce test immunologique PSP a re\u00e7u l’approbation convoit\u00e9e de la marque CE dans le cadre de la r\u00e9glementation sur les dispositifs m\u00e9dicaux de diagnostic in vitro (IVDR), ainsi qu’un enregistrement en Australie. Depuis son lancement, il a \u00e9t\u00e9 utilis\u00e9 dans plus de 20 pays et a jou\u00e9 un r\u00f4le d\u00e9terminant dans le diagnostic des patients des unit\u00e9s de soins intensifs dans de nombreux h\u00f4pitaux europ\u00e9ens. En outre, les pr\u00e9paratifs vont bon train en vue de l’autorisation 510(k) d’Abionic aupr\u00e8s de la FDA aux \u00c9tats-Unis.<\/p>\n\n\n\n

Dans le cadre de cette alliance strat\u00e9gique, Fapon re\u00e7oit le feu vert pour la recherche, le d\u00e9veloppement, la fabrication et la commercialisation de r\u00e9actifs \u00e0 base de PSP sur le vaste march\u00e9 chinois. Bien que les d\u00e9tails financiers restent confidentiels, ce partenariat en dit long sur la confiance croissante dans les capacit\u00e9s d’Abionic et sur la demande croissante de solutions de pointe pour le diagnostic du sepsis.<\/p>\n\n\n\n

Pour Fapon, cette collaboration s’inscrit dans sa vision globale. En tant qu’entreprise d\u00e9di\u00e9e \u00e0 la d\u00e9couverte et \u00e0 la recherche de biomarqueurs, l’obtention de la licence PSP augmentera de mani\u00e8re significative son incursion dans le domaine du diagnostic des maladies infectieuses.<\/p>\n","protected":false},"excerpt":{"rendered":"

Les soci\u00e9t\u00e9s du Biop\u00f4le, Abionic et Lascco, s’associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie, am\u00e9liorant ainsi les capacit\u00e9s de diagnostic pr\u00e9coce.<\/p>\n","protected":false},"author":6,"featured_media":20984,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1210,1181,1163],"class_list":["post-20988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-diagnostic-fr-2","tag-medical-devices-fr","tag-medtech-fr-2"],"acf":[],"yoast_head":"\nAbionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine<\/title>\n<meta name=\"description\" content=\"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine\" \/>\n<meta property=\"og:description\" content=\"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-02T09:45:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-02T09:47:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1161\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Abionic et Lascco s’associent \u00e0 Fapon pour le diagnostic du sepsis en Chine\",\"datePublished\":\"2023-11-02T09:45:21+00:00\",\"dateModified\":\"2023-11-02T09:47:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\"},\"wordCount\":500,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\",\"name\":\"Abionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png\",\"datePublished\":\"2023-11-02T09:45:21+00:00\",\"dateModified\":\"2023-11-02T09:47:28+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png\",\"width\":1161,\"height\":811,\"caption\":\"Ce partenariat strat\u00e9gique permettra \u00e0 Fapon de rechercher, d\u00e9velopper, fabriquer et vendre sur le march\u00e9 chinois des mat\u00e9riaux PSP et des solutions utilisant le test immunologique par chimiluminescence (CLIA).\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abionic et Lascco s’associent \u00e0 Fapon pour le diagnostic du sepsis en Chine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine","description":"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/","og_locale":"fr_FR","og_type":"article","og_title":"Abionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine","og_description":"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.","og_url":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-11-02T09:45:21+00:00","article_modified_time":"2023-11-02T09:47:28+00:00","og_image":[{"width":1161,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Abionic et Lascco s’associent \u00e0 Fapon pour le diagnostic du sepsis en Chine","datePublished":"2023-11-02T09:45:21+00:00","dateModified":"2023-11-02T09:47:28+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/"},"wordCount":500,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png","keywords":["Biotech","Diagnostic","Medical Devices","Medtech"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/","url":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/","name":"Abionic s'associe \u00e0 Fapon pour le diagnostic du sepsis en Chine","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png","datePublished":"2023-11-02T09:45:21+00:00","dateModified":"2023-11-02T09:47:28+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Abionic et Lascco s'associent \u00e0 Fapon pour exploiter un biomarqueur r\u00e9volutionnaire pour la d\u00e9tection de la septic\u00e9mie.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Abionic_Fapon_Lasco-1180x811-1.png","width":1161,"height":811,"caption":"Ce partenariat strat\u00e9gique permettra \u00e0 Fapon de rechercher, d\u00e9velopper, fabriquer et vendre sur le march\u00e9 chinois des mat\u00e9riaux PSP et des solutions utilisant le test immunologique par chimiluminescence (CLIA)."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/abionic-et-lascco-sassocient-a-fapon-pour-le-diagnostic-du-sepsis-en-chine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Abionic et Lascco s’associent \u00e0 Fapon pour le diagnostic du sepsis en Chine"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=20988"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20988\/revisions"}],"predecessor-version":[{"id":20990,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20988\/revisions\/20990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/20984"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=20988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=20988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=20988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}